Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Monoclate-P 500unit inj vials
0211000I0BCACAC
|
Monoclate-P | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 1,000unit inj pfs
0211000I0AAASAS
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 1,000unit inj vials
0211000I0AABBBB
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 2,000unit inj pfs
0211000I0AAAQAQ
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 2,000unit inj vials
0211000I0AAAZAZ
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 250unit inj pfs
0211000I0AAATAT
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 250unit inj vials
0211000I0AAAYAY
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 3,000unit inj pfs
0211000I0AAARAR
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 500unit inj pfs
0211000I0AAAUAU
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Moroctocog alfa 500unit inj vials
0211000I0AABABA
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Octanate LV 1,000unit inj vials
0211000I0BSACBG
|
Octanate LV | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Octanate LV 500unit inj vials
0211000I0BSADBF
|
Octanate LV | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Octocog alfa 1,000unit inj vials
0211000I0AAAHAH
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Octocog alfa 1,500unit inf vials
0211000I0AAALAL
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Octocog alfa 2,000unit inj vials
0211000I0AAAIAI
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Octocog alfa 250unit inj vials
0211000I0AAAFAF
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Octocog alfa 3,000unit inf vials
0211000I0AAAPAP
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Octocog alfa 500unit inj vials
0211000I0AAAGAG
|
Factor VIII Fraction | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Optivate 1,000unit inf vials
0211000I0BLABAX
|
Optivate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Optivate 250unit inf vials
0211000I0BLACBC
|
Optivate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Optivate 500unit inf vials
0211000I0BLAAAW
|
Optivate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Recombinate 1,000unit inj vials
0211000I0BFABAH
|
Recombinate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Recombinate 500unit inj vials
0211000I0BFAAAG
|
Recombinate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
ReFacto 1,000unit inj vials
0211000I0BGACBB
|
ReFacto | Dried factor VIII fraction | Cardiovascular System | No data available |
|
ReFacto 2,000unit inj vials
0211000I0BGADAZ
|
ReFacto | Dried factor VIII fraction | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.